These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28948854)

  • 41. Structural features of ultradeformable archaeosomes for topical delivery of ovalbumin.
    Carrer DC; Higa LH; Tesoriero MV; Morilla MJ; Roncaglia DI; Romero EL
    Colloids Surf B Biointerfaces; 2014 Sep; 121():281-9. PubMed ID: 24974012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coenzyme Q10 in vesicles composed of archaeal ether lipids or conventional lipids enhances the immuno-adjuvanticity to encapsulated protein.
    Makabi-Panzu B; Sprott GD; Patel GB
    Vaccine; 1998 Oct; 16(16):1504-10. PubMed ID: 9711796
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elastic liposome-mediated transdermal immunization enhanced the immunogenicity of P. falciparum surface antigen, MSP-119.
    Tyagi RK; Garg NK; Jadon R; Sahu T; Katare OP; Dalai SK; Awasthi A; Marepally SK
    Vaccine; 2015 Aug; 33(36):4630-8. PubMed ID: 26141014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Chiral Purity on Adjuvanticity of Archaeol-Based Glycolipids.
    Régnier S; Lam E; Vasquez V; Martinez-Farina CF; Stark FC; Agbayani G; Deschatelets L; Dudani R; Harrison BA; Akache B; McCluskie MJ; Hemraz UD
    J Med Chem; 2022 Jun; 65(12):8332-8344. PubMed ID: 35658102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Archaeosomes with encapsulated antigens for oral vaccine delivery.
    Li Z; Zhang L; Sun W; Ding Q; Hou Y; Xu Y
    Vaccine; 2011 Jul; 29(32):5260-6. PubMed ID: 21609747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Archaeal lipids in oral delivery of therapeutic peptides.
    Jacobsen AC; Jensen SM; Fricker G; Brandl M; Treusch AH
    Eur J Pharm Sci; 2017 Oct; 108():101-110. PubMed ID: 28108360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The potent in vitro skin permeation of archaeosome made from lipids extracted of Sulfolobus acidocaldarius.
    Moghimipour E; Kargar M; Ramezani Z; Handali S
    Archaea; 2013; 2013():782012. PubMed ID: 24453698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro assessment of archaeosome stability for developing oral delivery systems.
    Patel GB; Agnew BJ; Deschatelets L; Fleming LP; Sprott GD
    Int J Pharm; 2000 Jan; 194(1):39-49. PubMed ID: 10601683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of new glycosylation methodologies for the synthesis of archaeal-derived glycolipid adjuvants.
    Whitfield DM; Yu SH; Dicaire CJ; Sprott GD
    Carbohydr Res; 2010 Jan; 345(2):214-29. PubMed ID: 20004891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Archaeosomes: an excellent carrier for drug and cell delivery.
    Kaur G; Garg T; Rath G; Goyal AK
    Drug Deliv; 2016 Sep; 23(7):2497-2512. PubMed ID: 25777339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isopranoid- and dipalmitoyl-aminophospholipid adjuvants impact differently on longevity of CTL immune responses.
    Dicaire CJ; Yu SH; Whitfield DM; Sprott GD
    J Liposome Res; 2010 Dec; 20(4):304-14. PubMed ID: 20148707
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Homologous Prime-Boost Vaccination with OVA Entrapped in Self-Adjuvanting Archaeosomes Induces High Numbers of OVA-Specific CD8⁺ T Cells that Protect Against Subcutaneous B16-OVA Melanoma.
    Stark FC; McCluskie MJ; Krishnan L
    Vaccines (Basel); 2016 Nov; 4(4):. PubMed ID: 27869670
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparation, characterization, and in vitro evaluation of isoniazid and rifampicin-loaded archaeosomes.
    Attar A; Bakir C; Yuce-Dursun B; Demir S; Cakmakci E; Danis O; Birbir M; Ogan A
    Chem Biol Drug Des; 2018 Jan; 91(1):153-161. PubMed ID: 28667670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis of archaeal glycolipid adjuvants-what is the optimum number of sugars?
    Whitfield DM; Eichler EE; Sprott GD
    Carbohydr Res; 2008 Sep; 343(14):2349-60. PubMed ID: 18667197
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The potent adjuvant activity of archaeosomes correlates to the recruitment and activation of macrophages and dendritic cells in vivo.
    Krishnan L; Sad S; Patel GB; Sprott GD
    J Immunol; 2001 Feb; 166(3):1885-93. PubMed ID: 11160236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combinations of nanovesicles and physical methods for enhanced transdermal delivery of a model hydrophilic drug.
    Zorec B; Zupančič Š; Kristl J; Pavšelj N
    Eur J Pharm Biopharm; 2018 Jun; 127():387-397. PubMed ID: 29581043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Archaeal lipid mucosal vaccine adjuvant and delivery system.
    Patel GB; Chen W
    Expert Rev Vaccines; 2010 Apr; 9(4):431-40. PubMed ID: 20370552
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of formulation and follicular pathway in voriconazole cutaneous delivery from liposomes and nanostructured lipid carriers.
    Santos GA; Angelo T; Andrade LM; Silva SMM; Magalhães PO; Cunha-Filho M; Gelfuso GM; Taveira SF; Gratieri T
    Colloids Surf B Biointerfaces; 2018 Oct; 170():341-346. PubMed ID: 29940500
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthetic archaeosome vaccines containing triglycosylarchaeols can provide additive and long-lasting immune responses that are enhanced by archaetidylserine.
    Sprott GD; Yeung A; Dicaire CJ; Yu SH; Whitfield DM
    Archaea; 2012; 2012():513231. PubMed ID: 23055819
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo investigation of twin-screw extruded lipid implants for vaccine delivery.
    Even MP; Young K; Winter G; Hook S; Engert J
    Eur J Pharm Biopharm; 2014 Jul; 87(2):338-46. PubMed ID: 24607791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.